000 01012 a2200277 4500
005 20250518000409.0
008 ####s 0 0 eng d
022 _a1178-6930
024 7 _a10.2147/OTT.S170736
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRusz, Orsolya
245 0 0 _aClinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series.
_h[electronic resource]
260 _bOncoTargets and therapy
_c2018
300 _a5459-5463 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aKószó, Renáta
700 1 _aDobi, Ágnes
700 1 _aCsenki, Melinda
700 1 _aValicsek, Erzsébet
700 1 _aNikolényi, Alíz
700 1 _aUhercsák, Gabriella
700 1 _aCserháti, Adrienne
700 1 _aKahán, Zsuzsanna
773 0 _tOncoTargets and therapy
_gvol. 11
_gp. 5459-5463
856 4 0 _uhttps://doi.org/10.2147/OTT.S170736
_zAvailable from publisher's website
999 _c28853062
_d28853062